HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alterations in cell surface carbohydrate composition of a human colon carcinoma cell line affect adhesion to extracellular matrix components.

Abstract
The adhesion of HT29 human colon adenocarcinoma cells to different extracellular matrix components was studied. While treatment of the cells with sialidase had no detectable effect on binding to laminin and fibronectin, attachment to collagen IV was decreased. However, additional removal of beta-(1-4)-bound galactose led to significantly reduced binding to all of the substrates, including fibronectin and laminin. Tunicamycin treatment, monitored by lectin-induced aggregation, drastically diminished cell adhesion to laminin and fibronectin, whereas cell binding to collagen IV was not affected. Arg-Gly-Asp (RGD)-related peptides were used to study the adhesion to collagen IV. The results show that a serine-containing RGD-related peptide GRGDSP has virtually no effect on colon carcinoma cell adhesion to type IV collagen. In contrast, when serine was substituted for threonine (GRGDTP) adhesion to collagen IV was strongly inhibited. After incubation of sialidase-treated cells with the threonine-containing peptide adhesion was almost totally blocked. These results demonstrate the existence of both RGD-dependent and carbohydrate-based mechanisms for metastatic human HT29 cell binding to collagen IV.
AuthorsW Kemmner, J Morgenthaler, R Brossmer
JournalBiochimie (Biochimie) Vol. 74 Issue 1 Pg. 117-22 (Jan 1992) ISSN: 0300-9084 [Print] France
PMID1576204 (Publication Type: Journal Article)
Chemical References
  • Carbohydrates
  • Extracellular Matrix Proteins
  • Fibronectins
  • Laminin
  • Collagen
Topics
  • Adenocarcinoma (metabolism)
  • Carbohydrates (analysis)
  • Cell Adhesion
  • Cell Membrane (chemistry)
  • Collagen (metabolism)
  • Colonic Neoplasms (metabolism)
  • Extracellular Matrix Proteins (metabolism)
  • Fibronectins (metabolism)
  • Humans
  • Laminin (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: